↓ Skip to main content

Non-superiority of Kakkonto, a Japanese Herbal Medicine, to a Representative Multiple Cold Medicine with Respect to Anti-aggravation Effects on the Common Cold: A Randomized Controlled Trial

Overview of attention for article published in Internal Medicine, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
35 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Non-superiority of Kakkonto, a Japanese Herbal Medicine, to a Representative Multiple Cold Medicine with Respect to Anti-aggravation Effects on the Common Cold: A Randomized Controlled Trial
Published in
Internal Medicine, May 2014
DOI 10.2169/internalmedicine.53.1783
Pubmed ID
Authors

Satoe Okabayashi, Masashi Goto, Takashi Kawamura, Hidetsuna Watanabe, Akira Kimura, Reiko Uruma, Yuko Takahashi, Setsuko Taneichi, Manabu Musashi, Koichi Miyaki

Abstract

Kakkonto, a Japanese herbal medicine, is frequently used to treat the common cold not only with a physician's prescription, but also in self-medication situations. This study aimed to examine whether Kakkonto prevents the aggravation of cold symptoms if taken at an early stage of illness compared with a well-selected Western-style multiple cold medicine.

X Demographics

X Demographics

The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 46 98%

Demographic breakdown

Readers by professional status Count As %
Other 8 17%
Student > Ph. D. Student 7 15%
Researcher 6 13%
Student > Bachelor 3 6%
Student > Master 3 6%
Other 6 13%
Unknown 14 30%
Readers by discipline Count As %
Medicine and Dentistry 19 40%
Pharmacology, Toxicology and Pharmaceutical Science 6 13%
Nursing and Health Professions 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Business, Management and Accounting 1 2%
Other 2 4%
Unknown 16 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2023.
All research outputs
#1,646,680
of 25,371,288 outputs
Outputs from Internal Medicine
#59
of 2,937 outputs
Outputs of similar age
#16,121
of 242,173 outputs
Outputs of similar age from Internal Medicine
#2
of 13 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,937 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,173 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.